Tioga County Department Of Mental Hygiene Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 1062 State Route 38, Owego, NY 13827 Phone: 607-687-0200 Fax: 607-687-0248 |
Tioga County Alcohol And Drug Services Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1062 State Route 38, Owego, NY 13827 Phone: 607-687-0200 Fax: 607-687-0248 |
Hea Hea, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 537 Glenmary Dr, Owego, NY 13827 Phone: 607-731-6167 |
Southern Tier Counseling Solutions Lcsw Pllc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 383 Glenmary Dr Ste 1, Owego, NY 13827 Phone: 607-218-2010 Fax: 607-348-1483 |
News Archive
An emergency medicine researcher at Wake Forest University Baptist Medical Center has just published the first large, independent study of injuries from conducted electrical weapon (CEW) or Taser use, finding that serious injuries occurred in fewer than 1 percent of 1,201 Taser uses by law enforcement officers.
Research led by a cancer biologist at The Cleveland Clinic Lerner Research Institute has identified a molecular mechanism that links the body's internal clock to daily variations in how a patient responds to cancer treatment.
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study.Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT), which has examined the comparative value of different blood pressure-lowering medications.
FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, today announced the launch of the "THE ANTIBODY SERIES" - a 1-day conference bringing together top experts in the antibody field to explore the latest innovation within antibody drug discovery.
Promega Corporation announces it will provide FuGENE HD Transfection Reagent throughout the life science market. The comprehensive, direct use offering from Promega means any life scientist can utilize FuGENE technology with no licensing requirements. FuGENE HD enables the transfection of DNA into many cell types with high efficiency and little-to-no toxicity.
› Verified 4 days ago